Status:
COMPLETED
Attain Performa™ Left Ventricular (LV) Quadripolar Leads Chronic Performance Study
Lead Sponsor:
Medtronic
Conditions:
Heart Failure
Eligibility:
All Genders
Brief Summary
Lead survivability will be summarized.
Detailed Description
The purpose of this study is to evaluate long-term performance of the Attain Performa™ LV Leads. This evaluation is based on the number of lead-related complications occurring during the study compare...
Eligibility Criteria
Inclusion
- Patients who meet all of the following inclusion criteria and do not meet any of the following exclusion criteria are eligible for enrollment.
- Inclusion Criteria
- Patient or legally authorized representative provides written authorization and/or consent per institution and geographical requirements
- Patient has or is intended to receive an Attain Performa™ LV lead
- Patient within 30 day post implant enrollment window
- Exclusion Criteria
- Patient who is, or is expected to be inaccessible for follow-up
- Patient with exclusion criteria required by local law
- Patient is currently enrolled in or plans to enroll in any concurrent drug and/or device study that may confound results
Exclusion
Key Trial Info
Start Date :
August 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 31 2021
Estimated Enrollment :
1900 Patients enrolled
Trial Details
Trial ID
NCT02294331
Start Date
August 1 2014
End Date
July 31 2021
Last Update
February 1 2022
Active Locations (100)
Enter a location and click search to find clinical trials sorted by distance.
1
Birmingham, Alabama, United States, 35294
2
Anchorage, Alaska, United States, 99508
3
Chandler, Arizona, United States, 85226
4
Gilbert, Arizona, United States, 85295